143 related articles for article (PubMed ID: 19914223)
1. Zolpidem is a potent anticonvulsant in adult and aged mice.
Vlainić J; Pericić D
Brain Res; 2010 Jan; 1310():181-8. PubMed ID: 19914223
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam.
Vlainić J; Pericić D
Neuropharmacology; 2009 Jun; 56(8):1124-30. PubMed ID: 19345234
[TBL] [Abstract][Full Text] [Related]
3. Acute zolpidem administration produces pharmacodynamic and receptor occupancy changes at similar doses.
Fahey JM; Grassi JM; Reddi JM; Greenblatt DJ
Pharmacol Biochem Behav; 2006 Jan; 83(1):21-7. PubMed ID: 16439007
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice.
Hansen SL; Sperling BB; Sánchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):105-13. PubMed ID: 14687864
[TBL] [Abstract][Full Text] [Related]
5. Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism.
Akula KK; Dhir A; Kulkarni SK
Epilepsy Res; 2008 Jan; 78(1):60-70. PubMed ID: 18054463
[TBL] [Abstract][Full Text] [Related]
6. L-deprenyl (selegiline) exerts anticonvulsant effects against different seizure types in mice.
Löscher W; Lehmann H
J Pharmacol Exp Ther; 1996 Jun; 277(3):1410-7. PubMed ID: 8667204
[TBL] [Abstract][Full Text] [Related]
7. Anti-epileptogenic effect of beta-carotene and vitamin A in pentylenetetrazole-kindling model of epilepsy in mice.
Sayyah M; Yousefi-Pour M; Narenjkar J
Epilepsy Res; 2005 Jan; 63(1):11-6. PubMed ID: 15716082
[TBL] [Abstract][Full Text] [Related]
8. Voltage-dependent calcium channel and NMDA receptor antagonists augment anticonvulsant effects of lithium chloride on pentylenetetrazole-induced clonic seizures in mice.
Ghasemi M; Shafaroodi H; Nazarbeiki S; Meskar H; Heydarpour P; Ghasemi A; Talab SS; Ziai P; Bahremand A; Dehpour AR
Epilepsy Behav; 2010 Jul; 18(3):171-8. PubMed ID: 20605531
[TBL] [Abstract][Full Text] [Related]
9. Sedative and anticonvulsant effects of zolpidem in adult and aged mice.
Pericić D; Vlainić J; Strac DS
J Neural Transm (Vienna); 2008 Jun; 115(6):795-802. PubMed ID: 18217189
[TBL] [Abstract][Full Text] [Related]
10. The role of 5-HT(3) receptors in the additive anticonvulsant effects of citalopram and morphine on pentylenetetrazole-induced clonic seizures in mice.
Bahremand A; Payandemehr B; Rahimian R; Ziai P; Pourmand N; Loloee S; Ebrahimi A; Ghasemi A; Fakhfouri G; Ghasemi M; Dehpour AR
Epilepsy Behav; 2011 Jun; 21(2):122-7. PubMed ID: 21531632
[TBL] [Abstract][Full Text] [Related]
11. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.
Perrault G; Morel E; Sanger DJ; Zivkovic B
J Pharmacol Exp Ther; 1992 Oct; 263(1):298-303. PubMed ID: 1403792
[TBL] [Abstract][Full Text] [Related]
12. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
[TBL] [Abstract][Full Text] [Related]
13. The synergistic anticonvulsant effect of agmatine and morphine: possible role of alpha 2-adrenoceptors.
Riazi K; Honar H; Homayoun H; Rashidi N; Kiani S; Ebrahimkhani MR; Noorian AR; Ghaffari K; Jannati A; Dehpour AR
Epilepsy Res; 2005 Jun; 65(1-2):33-40. PubMed ID: 15975766
[TBL] [Abstract][Full Text] [Related]
14. Role of ATP-sensitive potassium channels in the biphasic effects of morphine on pentylenetetrazole-induced seizure threshold in mice.
Shafaroodi H; Asadi S; Sadeghipour H; Ghasemi M; Ebrahimi F; Tavakoli S; Hajrasouliha AR; Dehpour AR
Epilepsy Res; 2007 Jun; 75(1):63-9. PubMed ID: 17517498
[TBL] [Abstract][Full Text] [Related]
15. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
[TBL] [Abstract][Full Text] [Related]
17. Gaboxadol -- a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing.
Ebert B; Anderson NJ; Cremers TI; Rasmussen S; Vogel V; Fahey JM; Sánchez C
Pharmacol Biochem Behav; 2008 Jul; 90(1):113-22. PubMed ID: 18304623
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of the hypnotic zolpidem in vivo.
Crestani F; Martin JR; Möhler H; Rudolph U
Br J Pharmacol; 2000 Dec; 131(7):1251-4. PubMed ID: 11090095
[TBL] [Abstract][Full Text] [Related]
19. N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice.
Assi AA
J Pharm Pharm Sci; 2001; 4(1):42-51. PubMed ID: 11302789
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of anticonvulsant and analgesic effects of benzyl- and benzhydryl ureides.
Librowski T; Kubacka M; Meusel M; Scolari S; Müller CE; Gütschow M
Eur J Pharmacol; 2007 Mar; 559(2-3):138-49. PubMed ID: 17250826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
